Hosted on MSN47m
Regeneron Gets Positive CHMP Opinion for Multiple Myeloma DrugRegeneron Pharmaceuticals, Inc. REGN obtained positive opinion for its pipeline candidate linvoseltamab from the European ...
Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s ...
Regeneron has won a court ruling that will make it harder for U.S. authorities to win a lawsuit accusing it of paying illegal ...
Ten out of 11 children with a form of congenital deafness who were treated with an experimental gene therapy developed by ...
We recently compiled a list of the 15 Stocks That Will Go to The Moon According to Analysts. In this article, we are going to ...
The general mood among these heavyweight investors is divided, with 62% leaning bullish and 18% bearish. Among these notable ...
Regeneron Pharmaceuticals said on Monday its experimental gene therapy showed improved hearing in 10 of 11 children between ...
Regeneron Pharmaceuticals Inc. REGN stock has gone relatively unnoticed from major headlines in 2024 as GLP-1 makers like Novo Nordisk A/S NVO and Eli Lilly & Co. LLY grabbed the spotlight. Its ...
OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback